Candel Therapeutics, Inc.
Developing off-the-shelf viral immunotherapies to help the immune system fight solid tumors.
CADL | NDAQ
Overview
Corporate Details
- ISIN(s):
- US1374041093
- LEI:
- Country:
- United States of America
- Address:
- 117 KENDRICK STREET, 2494 NEEDHAM
- Website:
- https://www.candeltx.com/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
Candel Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on developing off-the-shelf viral immunotherapies to help patients fight cancer. The company's approach is designed to stimulate a patient's immune system to create a personalized, systemic, and long-lasting response against their specific tumor. This is achieved by using engineered viruses to induce immunogenic cell death at the injection site, effectively creating an "in situ vaccination." Candel's pipeline, which includes candidates like CAN-2409 and CAN-3110, is being evaluated in clinical trials for various solid tumors, such as prostate, brain, lung, and pancreatic cancers. The company aims to provide efficacious and well-tolerated treatments for patients across different disease stages.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all Candel Therapeutics, Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Candel Therapeutics, Inc.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Candel Therapeutics, Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
